A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
Winter JM, Tang LH, Klimstra DS, Brennan MF, Brody JR, Rocha FG, Jia X, Qin LX, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, O'Reilly EM, Allen PJ.
Winter JM, et al.
PLoS One. 2012;7(7):e40157. doi: 10.1371/journal.pone.0040157. Epub 2012 Jul 6.
PLoS One. 2012.
PMID: 22792233
Free PMC article.